Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Quidel Corp (QDEL) VTG USD0.001

Sell:$298.34 Buy:$298.57 Change: $4.74 (1.61%)
NASDAQ:0.35%
Market closed |  Prices as at close on 4 August 2020 | Switch to live prices |
Sell:$298.34
Buy:$298.57
Change: $4.74 (1.61%)
Market closed |  Prices as at close on 4 August 2020 | Switch to live prices |
Sell:$298.34
Buy:$298.57
Change: $4.74 (1.61%)
Market closed |  Prices as at close on 4 August 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Quidel Corp. is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: rapid immunoassays, cardiac immunoassay, specialized diagnostic solutions and molecular diagnostic solutions. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of many diseases and medical conditions, including infectious diseases, cardiovascular diseases and conditions, women’s health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Amplivue, Lyra and Thyretain.

Contact details

Address:
9975 Summers Ridge Road
SAN DIEGO
92121
United States
Telephone:
+1 (858) 5521100
Website:
www.quidel.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
QDEL
ISIN:
US74838J1016
Market cap:
$11.86 billion
Shares in issue:
42.00 million
Sector:
Health Care Supplies
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Kenneth Buechler
    Independent Chairman of the Board
  • Douglas Bryant
    President, Chief Executive Officer, Director
  • Randall Steward
    Chief Financial Officer
  • Robert Bujarski
    Senior Vice President - North America Commercial Operations, General Counsel
  • Michael Abney
    Senior Vice President - Distribution
  • Ratan Borkar
    Senior Vice President - International Commercial Operations
  • Karen Gibson
    Senior Vice President, Information Systems and Business Transformation
  • Werner Kroll
    Senior Vice President - R&D
  • Edward Russell
    Senior Vice President - Business Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.